Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| basal cell | 8 studies | 25% ± 13% | |
| endothelial cell | 6 studies | 20% ± 6% | |
| epithelial cell | 4 studies | 28% ± 10% | |
| fibroblast | 4 studies | 26% ± 5% | |
| transit amplifying cell | 3 studies | 35% ± 18% | |
| astrocyte | 3 studies | 22% ± 1% |
Insufficient scRNA-seq data for expression of LRIG3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 2629.29 | 966 / 966 | 98% | 23.09 | 517 / 527 |
| stomach | 100% | 2422.44 | 358 / 359 | 98% | 25.20 | 281 / 286 |
| thymus | 100% | 5653.73 | 653 / 653 | 98% | 60.45 | 592 / 605 |
| esophagus | 100% | 2803.31 | 1442 / 1445 | 97% | 33.45 | 178 / 183 |
| pancreas | 99% | 1767.21 | 326 / 328 | 97% | 30.31 | 173 / 178 |
| lung | 96% | 1485.11 | 557 / 578 | 97% | 35.88 | 1123 / 1155 |
| uterus | 100% | 2644.56 | 170 / 170 | 92% | 23.70 | 424 / 459 |
| prostate | 99% | 1734.40 | 242 / 245 | 89% | 12.61 | 449 / 502 |
| ovary | 100% | 2730.61 | 180 / 180 | 85% | 12.69 | 364 / 430 |
| bladder | 100% | 3406.05 | 21 / 21 | 84% | 19.05 | 422 / 504 |
| breast | 100% | 3210.94 | 458 / 459 | 77% | 12.01 | 865 / 1118 |
| skin | 100% | 4954.88 | 1809 / 1809 | 60% | 7.89 | 283 / 472 |
| kidney | 67% | 713.83 | 60 / 89 | 82% | 17.05 | 742 / 901 |
| liver | 54% | 404.29 | 122 / 226 | 55% | 12.02 | 222 / 406 |
| blood vessel | 100% | 2647.73 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 2952.37 | 1189 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 35.48 | 44 / 45 |
| spleen | 93% | 1105.52 | 224 / 241 | 0% | 0 | 0 / 0 |
| muscle | 54% | 423.93 | 435 / 803 | 0% | 0 | 0 / 0 |
| brain | 7% | 48.30 | 174 / 2642 | 43% | 4.43 | 302 / 705 |
| heart | 42% | 355.08 | 365 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 9% | 62.51 | 24 / 258 | 13% | 1.57 | 29 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 0.84 | 4 / 29 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.40 | 5 / 80 |
| peripheral blood | 4% | 36.22 | 39 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0032474 | Biological process | otolith morphogenesis |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LRIG3 |
| Protein name | Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3) Leucine rich repeats and immunoglobulin like domains 3 |
| Synonyms | LIG3 UNQ287/PRO326/PRO335 |
| Description | FUNCTION: May play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1 (By similarity). . |
| Accessions | ENST00000379141.8 [Q6UXM1-2] F8VYZ5 ENST00000433272.6 ENST00000550825.1 ENST00000320743.8 [Q6UXM1-1] Q6UXM1 H0YID8 ENST00000552267.1 C9K080 |
